Manufacturing / Biological Products, Except Diagnostic Substances
Outlook Therapeutics, Inc.
OTLK
$0.67
+$0.06 (+9.54%)
Price as of Aug 25, 2026 18:05 UTC
150 M
Market Cap (Micro Cap)
Dec 17
Next Earnings
Options Heat Map
Delta-risk grid for OTLK options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
15 buys
0 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | KENYON LAWRENCE A | Buy | 101,010 | $0 | |
| Aug 14, 2026 | KENYON LAWRENCE A | Buy | 101,010 | $0 | |
| Aug 14, 2026 | Jahr Robert Charles | Buy | 151,515 | $0 | |
| Aug 14, 2026 | Jahr Robert Charles | Buy | 151,515 | $0 | |
| Aug 12, 2026 | Sukhtian Ghiath M. | Buy | 2,525,252 | $2,499,999 | |
| Aug 12, 2026 | Sukhtian Ghiath M. | Buy | 2,525,252 | $0 | |
| Jul 29, 2026 | Sukhtian Faisal Ghiath | Buy | 95,398 | $99,996 | |
| Jul 21, 2026 | Jahr Robert Charles | Grant | 100,000 | $0 | |
| Jul 21, 2026 | KENYON LAWRENCE A | Grant | 210,078 | $0 | |
| Jun 02, 2026 | Haddadin Yezan Munther | Buy | 29,000 | $24,145 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 14, 2026 | Q3 2026 | -$0.10 | |||
| Aug 12, 2026 | Q3 2026 | -$0.10 | |||
| Jun 30, 2026 | Q3 2026 | -$0.10 | -$0.09 | +5.5% | Beat |
| Mar 31, 2026 | Q2 2026 | -$0.12 | -$0.16 | -30.7% | Miss |
| Dec 31, 2025 | Q1 2026 | -$0.18 | -$0.22 | -24.4% | Miss |
| Sep 30, 2025 | Q4 2025 | -$0.26 | -$0.19 | +26.5% | Beat |
Track OTLK with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for OTLK and your entire portfolio.